BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26509911)

  • 21. Expression of FRS2 in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: an immunohistochemical analysis of 182 cases with genetic data.
    Jing W; Lan T; Qiu Y; Peng R; Lu Y; Chen H; Chen M; He X; Chen C; Zhang H
    Diagn Pathol; 2021 Oct; 16(1):96. PubMed ID: 34696768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between retroperitoneal leiomyosarcoma and dedifferentiated liposarcoma.
    Ishii T; Kohashi K; Ootsuka H; Iura K; Maekawa A; Yamada Y; Bekki H; Yoshimoto M; Yamamoto H; Iwamoto Y; Oda Y
    Pathol Res Pract; 2017 Jun; 213(6):634-638. PubMed ID: 28552535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas.
    Binh MB; Guillou L; Hostein I; Château MC; Collin F; Aurias A; Binh BN; Stoeckle E; Coindre JM
    Am J Surg Pathol; 2007 Oct; 31(10):1557-66. PubMed ID: 17895758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Well-differentiated liposarcoma with low-grade osteosarcomatous component: an underrecognized variant.
    Yoshida A; Ushiku T; Motoi T; Shibata T; Fukayama M; Tsuda H
    Am J Surg Pathol; 2010 Sep; 34(9):1361-6. PubMed ID: 20697254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of MDM2 and p16 in angiomyolipoma.
    Lin X; Laskin WB; Lu X; Zhang Y
    Hum Pathol; 2018 May; 75():34-40. PubMed ID: 29432785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours.
    Aleixo PB; Hartmann AA; Menezes IC; Meurer RT; Oliveira AM
    J Clin Pathol; 2009 Dec; 62(12):1127-35. PubMed ID: 19946100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
    Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X
    Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
    Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retroperitoneal dedifferentiated liposarcoma with osteosarcomatous components: a case report.
    Fujii T; Arai T; Sakon M; Sawano S; Momose Y; Ishii K; Miwa S
    Int J Clin Exp Pathol; 2013; 6(7):1427-31. PubMed ID: 23826426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?
    Alshenawy H
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):1073-81. PubMed ID: 23529275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dedifferentiated liposarcoma of extremities: a clinicopathologic analysis].
    Gong LH; Liu WF; Ding Y; Li L; Zhang M; Sun XQ; Huang XY
    Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):511-516. PubMed ID: 29996315
    [No Abstract]   [Full Text] [Related]  

  • 32. MDM2-positive papillary sarcomatoid renal cell carcinoma: a potential diagnostic pitfall.
    Jeruc J; Čugura T; Tomažič A; Boštjančič E
    Virchows Arch; 2020 May; 476(5):783-786. PubMed ID: 31732813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunostaining for peroxisome proliferator gamma distinguishes dedifferentiated liposarcoma from other retroperitoneal sarcomas.
    Horvai AE; Schaefer JT; Nakakura EK; O'Donnell RJ
    Mod Pathol; 2008 May; 21(5):517-24. PubMed ID: 18204431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well-differentiated and dedifferentiated liposarcoma oncogenesis: an analysis of 104 tumors.
    Louis-Brennetot C; Coindre JM; Ferreira C; Pérot G; Terrier P; Aurias A
    Genes Chromosomes Cancer; 2011 Nov; 50(11):896-907. PubMed ID: 21910158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
    Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
    Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases].
    Si HP; Wang Z; Fan QH; Zhang YF; Yang DQ; Zhang ZH; Gong QX
    Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):282-287. PubMed ID: 30955263
    [No Abstract]   [Full Text] [Related]  

  • 37. MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors?: A New Perspective.
    Clay MR; Martinez AP; Weiss SW; Edgar MA
    Am J Surg Pathol; 2016 Dec; 40(12):1647-1652. PubMed ID: 27508976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retroperitoneal dedifferentiated liposarcoma with huge cystic degeneration: A case report.
    Uchihashi K; Matsuyama A; Shiba E; Kimura Y; Ogata T; Yabuki K; Harada H; Kubo C; Tsuda Y; Jotatsu M; Hisaoka M
    Pathol Int; 2017 May; 67(5):264-268. PubMed ID: 28337832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
    Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A
    Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.
    Italiano A; Bianchini L; Gjernes E; Keslair F; Ranchere-Vince D; Dumollard JM; Haudebourg J; Leroux A; Mainguené C; Terrier P; Chibon F; Coindre JM; Pedeutour F
    Clin Cancer Res; 2009 Sep; 15(18):5696-703. PubMed ID: 19737942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.